Bortezomib inhibits chikungunya virus replication by interfering with viral protein synthesis.
Chikungunya virus (CHIKV) is an alphavirus that causes a febrile illness accompanied by myalgia and arthralgia. Despite having re-emerged as a significant public health threat, there are no approved therapeutics or prophylactics for CHIKV infection. In this study, we explored the anti-CHIKV effects...
Saved in:
Main Authors: | Parveen Kaur (Author), Laura Sandra Lello (Author), Age Utt (Author), Sujit Krishna Dutta (Author), Andres Merits (Author), Justin Jang Hann Chu (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proteomics profiling of chikungunya-infected Aedes albopictus C6/36 cells reveal important mosquito cell factors in virus replication.
by: Regina Ching Hua Lee, et al.
Published: (2015) -
Chikungunya virus requires cellular chloride channels for efficient genome replication.
by: Marietta Müller, et al.
Published: (2019) -
Characterization of Aedes aegypti innate-immune pathways that limit Chikungunya virus replication.
by: Melanie McFarlane, et al.
Published: (2014) -
A polarized cell model for Chikungunya virus infection: entry and egress of virus occurs at the apical domain of polarized cells.
by: Pei Jin Lim, et al.
Published: (2014) -
Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.
by: Ilhem Messaoudi, et al.
Published: (2013)